Clinical Trials Browser

Interventional × Rare Diseases × Infliximab × Clear all

NCT00004941 2015-03-25

Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease

Phase 3 Completed

Gastrointestinal

Crohn Disease, Gastrointestinal Diseases, Rare Diseases